Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Dominika Stastna"'
Autor:
Dominika Stastna, Jiri Drahota, Michal Lauer, Aneta Mazouchova, Ingrid Menkyova, Jana Adamkova, Radek Ampapa, Michal Dufek, Marketa Grunermelova, Pavel Hradilek, Eva Kubala Havrdova, Jan Mares, Alena Martinkova, Zbysek Pavelek, Marek Peterka, Eva Recmanova, Petra Rockova, Ivana Stetkarova, Pavel Stourac, Marta Vachova, Dana Horakova
Publikováno v:
Biomedical Papers, Vol 168, Iss 3, Pp 262-270 (2024)
Aims. Multiple sclerosis treatment strategies are changing in the Czech Republic. According to data from 2013-2021, the proportion of patients starting high-efficacy disease-modifying therapies is increasing. In this survey, we describe the actual da
Externí odkaz:
https://doaj.org/article/031942c91d96488a818590beaafcebd7
Autor:
Pavel Potuznik, Jiri Drahota, Dana Horakova, Marek Peterka, Aneta Mazouchova, David Matyas, Zbysek Pavelek, Marta Vachova, Eva Recmanova, Ivana Stetkarova, Jana Libertinova, Jan Mares, Pavel Stourac, Marketa Grunermelova, Alena Martinkova, Jana Adamkova, Pavel Hradilek, Radek Ampapa, Michal Dufek, Eva Kubala Havrdova, Dominika Stastna
Publikováno v:
Journal of Central Nervous System Disease, Vol 16 (2024)
Background Cladribine, a selective immune reconstitution therapy, is approved for the treatment of adult patients with highly active multiple sclerosis (MS). Objectives Provide experience with cladribine therapy in a real-world setting. Methods This
Externí odkaz:
https://doaj.org/article/184f4c6999bb4bada8b072f3e0cb99d2
Autor:
Petra Nytrova, Dominika Stastna, Adam Tesar, Ingrid Menkyova, Helena Posova, Helena Koprivova, Veronika Mikulova, Jiri Hrdy, Gabriela Smela, Dana Horakova, Irena Rysankova, Kristyna Doleckova, Michaela Tyblova
Publikováno v:
Frontiers in Immunology, Vol 14 (2023)
BackgroundRituximab (RTX) and ocrelizumab (OCR), B cell-depleting therapy targeting CD20 molecules, affect the humoral immune response after vaccination. How these therapies influence T-cell-mediated immune response against SARS-CoV-2 after immunizat
Externí odkaz:
https://doaj.org/article/fd83e3caa4d14846b4d386ffddd286ce
Autor:
Michaela Andelova, Karolina Vodehnalova, Jan Krasensky, Eliska Hardubejova, Tereza Hrnciarova, Barbora Srpova, Tomas Uher, Ingrid Menkyova, Dominika Stastna, Lucie Friedova, Jiri Motyl, Jana Lizrova Preiningerova, Eva Kubala Havrdova, Bénédicte Maréchal, Mário João Fartaria, Tobias Kober, Dana Horakova, Manuela Vaneckova
Publikováno v:
BMC Neurology, Vol 22, Iss 1, Pp 1-11 (2022)
Abstract Background Early infratentorial and focal spinal cord lesions on magnetic resonance imaging (MRI) are associated with a higher risk of long-term disability in patients with multiple sclerosis (MS). The role of diffuse spinal cord lesions rem
Externí odkaz:
https://doaj.org/article/4e0b4523cfb94fc49b3da5a0513014e1
Autor:
Dominika Stastna, Jiri Drahota, Michal Lauer, Aneta Mazouchova, Ingrid Menkyova, Jana Adamkova, Radek Ampapa, Michal Dufek, Marketa Grunermelova, Pavel Hradilek, Eva Kubala Havrdova, Jan Mares, Alena Martinkova, Zbysek Pavelek, Marek Peterka, Eva Recmanova, Petra Rockova, Ivana Stetkarova, Pavel Stourac, Marta Vachova, Dana Horakova
Publikováno v:
Biomedical Papers.
Autor:
Dominika Stastna, Ingrid Menkyova, Jiri Drahota, Tereza Hrnciarova, Eva Kubala Havrdova, Marta Vachova, Michaela Andelova, Pavlina Kleinova, Ivana Kovarova, Eva Krasulova, Jana Lizrova Preiningerova, Iveta Novakova, Klara Novotna, Martina Novotna, Petra Nytrova, Jana Pavlickova, Barbora Srpova, Katerina Storey, Veronika Ticha, Michaela Tyblova, Tomas Uher, Karolina Vodehnalova, Dana Horakova
Publikováno v:
Multiple Sclerosis and Related Disorders. 70:104549
Autor:
Dominika Stastna, Ingrid Menkyova, Jiri Drahota, Tereza Hrnciarova, Eva Kubala Havrdova, Marta Vachova, Michaela Andelova, Pavlina Kleinova, Ivana Kovarova, Eva Krasulova, Jana Lizrova Preiningerova, Iveta Novakova, Klara Novotna, Martina Novotna, Petra Nytrova, Jana Pavlickova, Barbora Srpova, Katerina Storey, Veronika Ticha, Michaela Tyblova, Tomas Uher, Karolina Vodehnalova, Dana Horakova
Publikováno v:
Multiple sclerosis and related disorders. 65
COVID-19 vaccination and infection are speculated to increase the activity of immune-mediated diseases, including multiple sclerosis (MS) and neuromyelitis optica spectrum disorder (NMOSD). The aim of this study was to evaluate a short-term risk of r
Autor:
Ivana Stetkarova, Martin Vališ, Radek Ampapa, J. Adamkova, Marek Peterka, Ivana Woznicova, Ingrid Menkyova, Eva Recmanova, Dominika Stastna, Aneta Mazouchova, Petra Rockova, Markéta Grünermelová, Jiri Drahota, Dana Horakova, Matous Rous, Marta Vachova
Publikováno v:
Multiple Sclerosis and Related Disorders
Background: When the novel coronavirus disease 2019 (COVID-19) appeared, concerns about its course in patients with multiple sclerosis (MS) and neuromyelitis optica spectrum disorder (NMOSD) arose. This study aimed to evaluate the incidence, severity